Fera Pharmaceuticals announced that Methazolamide (marketed as Neptazane) tablets will commence shipping June 1, 2012.

Methazolamide is a carbonic anhydrase inhibitor indicated in ocular conditions where lowering intraocular pressure would be of therapeutic benefit (eg, chronic open-angle glaucoma, secondary glaucoma, pre-op in acute angle-closure glaucoma). Carbonic anhydrase catalyzes the hydration of carbon dioxide and dehydration of carbonic acid that produces bicarbonate. By blocking this reaction, carbonic anhydrase inhibitors reduce bicarbonate synthesis which subsequently reduces aqueous transport and intraocular pressure.

Methazolamide had been in short supply but will soon be available again in 25mg and 50mg dosage strengths in 90-count bottles.

For more information call (414) 434-6604 or visit www.ferapharma.com.